You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Updates and Advances: The Latest Data on Neutralizing the COVID-19 Pandemic

  • Authors: Eric Daar, MD; Roger Bedimo, MD, MS
  • CME / ABIM MOC / CE Released: 2/24/2021
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 2/24/2022, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This educational activity is intended for infectious disease specialists, emergency medicine physicians, urgent care specialists, critical care specialists, hospitalists, and all other clinicians who encounter patients with mild to moderate disease at risk for severe coronavirus disease 2019 (COVID-19).

The goal of this activity is to provide clinicians with the latest data and information, as well as expert perspectives on the implications of such data on patient care strategies.

Upon completion of this activity, participants will:

  • Describe the latest data for monoclonal antibodies (mAbs) that have received emergency use authorization (EUA) for the treatment of COVID-19
  • Identify patient populations most likely to benefit from therapy with neutralizing antibodies (nAbs)


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Eric Daar, MD

    Harbor UCLA Medical Center
    David Geffen School of Medicine at UCLA
    Torrance, California

    Disclosures

    Disclosure: Eric Daar, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Genentech; Gilead; Merck & Co
    Received grants for clinical research from: Gilead; Merck & Co; Viiv Healthcare

  • Roger Bedimo, MD, MS

    VA North Texas Health Care System
    University of Texas
    Southwestern Medical Center
    Dallas, Texas

    Disclosures

    Disclosure: Roger Bedimo, MD, MS, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Merck & Co; Theratechnologies; Viiv Healthcare

Editors

  • Maria B. Uravich, BSc

    Lead Medical Education Director, WebMD Global, LLC 

    Disclosures

    Disclosure: Maria B. Uravich, BSc, has disclosed no relevant financial relationships.  

  • David Lemler, PhD

    Associate Medical Writer, WebMD Global, LLC 

    Disclosures

    Disclosure: David Lemler, PhD, has disclosed no relevant financial relationships.  

CME, CE Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships

NJAFP Reviewer

  • Angelia Halaja-Henriques

    Director of Business Development, NJAFP

    Disclosures

    Disclosure: Angelia Halaja-Henriques, has disclosed no relevant financial relationships.

IDSA Reviewer

  • Erin Bonura, MD MCR

    IDSA Education Committee, Chair

    Disclosures

    Disclosure: Erin Bonura, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.


Accreditation Statements

Developed through a partnership between Medscape and Infectious Diseases Society of America (IDSA), New Jersey Academy of Family Physicians (NJAFP).

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    The AAFP has reviewed Updates and Advances: The Latest Data on Neutralizing the COVID-19 Pandemic and deemed it acceptable for up to 0.25 Enduring Materials, Self-Study AAFP Prescribed credit. Term of Approval is from 02/26/2021 to 02/26/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Updates and Advances: The Latest Data on Neutralizing the COVID-19 Pandemic

Authors: Eric Daar, MD; Roger Bedimo, MD, MSFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC / CE Released: 2/24/2021

Valid for credit through: 2/24/2022, 11:59 PM EST

processing....

Educational Impact Challenge

The goal of this activity is to provide clinicians with the latest data and information, as well as expert perspectives on the implications of such data on patient care strategies.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print